This website is intended for HCP's. Visit the patient site

ULTHERAPY PRIME IS ADVANCED.

In comparison to the ULTHERAPY legacy device, ULTHERAPY PRIME’s advanced platform features1:

  • Elevated system performance
  • Ergonomic advances
  • Sophisticated design

Sophisticated-looking platform to meet the needs of modern aesthetics practices

Tiltable screen for optimal viewing angles

Integrated work surface to keep treatment equipment in place

Ergonomically angled cart platform for easy interaction with the device

Quiet system sounds relaxed treatment environment

Large 19-inch, high-resolution, capacitive touchscreen

Faster refresh rate of the ultrasound imaging due to new powerful system components

Instant response time to commands

10x faster processing performance through a new dual-core processor

Nearly twice as fast boot-up time from power on to use readiness

Improved stability and memory management paired with a new operating system and modern drivers to enable future software innovations

ULTHERAPY PRIME IS VIVID

The ULTHERAPY PRIME platform stands out with distinct attributes to elevate your visualisation experience.

Compared to the original ULTHERAPY, which has a 15-inch screen and a 7-inch ultrasound panel, ULTHERAPY PRIME now features a 35% larger screen, now 19 inches, and a larger ultrasound field, now 10 inches.1

Unique visualisation

35% larger screen

2x larger ultrasound field

Reduced visual noise for stable, clear imaging up to 8mm depth

Easy-to-use graphical user interface for intuitive workflows

Human avatar with modern, patient-resembling appeal

ULTHERAPY PRIME IS PROVEN

ULTHERAPY PRIME is the evolution of ULTHERAPY, the Gold Standard in non-invasive skin lifting and tightening with visualisation3.

  • 95% patient satisfaction at year one2
  • A strong clinical body of evidence with over 100 publications and 50 clinical studies4
  • 3 million treatments completed worldwide4

INTRODUCE ULTHERAPY PRIME TO YOUR PRACTICE TODAY

Get in touch

REFERENCES

  1. Merz Data on File (REF-1920)
  2. Werschler WP & Werschler PS. J Clin Aesthet Dermatol. 2016;9(2);27-33
  3. Fabi SG, et al. J Drugs Dermatol. 2019;18(5):426-432
  4. Merz Data on File (REF-1799)

M-ULT-UKI-1691 Date of Preparation February 2025